Status:
UNKNOWN
Decrease Implantation Site INFECTION : a Randomized Controlled Trial
Lead Sponsor:
Yong Seog Oh
Conditions:
Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted the investigators investigated recent trends and possible cause...
Detailed Description
There are many studies on the preventive use of Antibiotics or povidone iodine to Cardiovascular implantable electronic device (CIED) infections. But, studies of posterior pocket capsule removal is s...
Eligibility Criteria
Inclusion
- scheduled for cardiac devices replacement
Exclusion
- under the age of 18
- take an antibiotic
- history of infection within 30 days
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT02217046
Start Date
December 1 2013
End Date
October 1 2025
Last Update
April 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul St Mary's Hospital
Seoul, Seo Ch-gu, South Korea, 137-701